Alnylam Pharmaceuticals, Inc. Common Stock (ALNY)

$289.18 -0.73%
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-07-17 ESTIMATED
search

Alnylam Pharmaceuticals, Inc. Common Stock (ALNY) has reported earnings 16 times since Aug 03, 2021. The stock moves an average of ±5.29% the day after reporting, closing higher 50.0% of the time. Its largest post-earnings gain was +15.47% (Jul 31, 2025) and its largest decline was -15.23% (Oct 28, 2021). The next earnings report is predicted for 2026-07-17 (estimated).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

16

Avg Abs. Movement

±5.29%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
Apr 30, 2026 ☀ PRE $303.74 $317.54 $309.37 144,552 +2.74% open_in_new
Feb 12, 2026 ☀ PRE $313.06 $314.52 $308.42 198,872 -4.2% open_in_new
Oct 30, 2025 ☀ PRE $451.20 $472.36 $449.75 182,519 -6.71% open_in_new
Jul 31, 2025 ☀ PRE $356.15 $401.76 $391.83 209,831 +15.47% open_in_new
Jan 13, 2025 ☀ PRE $241.00 $261.27 $258.18 85,543 +7.5% open_in_new
Feb 15, 2024 ☀ PRE $149.99 $152.98 $147.41 436,068 -10.21% open_in_new
Nov 02, 2023 ☀ PRE $159.85 $163.20 $161.43 31,818 +2.8% open_in_new
Aug 03, 2023 ☀ PRE $181.07 $192.18 $189.97 31,230 +1.54% open_in_new
May 04, 2023 ☀ PRE $203.50 $206.26 $205.34 53,725 +2.92% open_in_new
Feb 23, 2023 ☀ PRE $196.99 $201.62 $195.91 138,926 -2.58% open_in_new
Oct 27, 2022 ☀ PRE $197.50 $198.19 $194.11 352,405 -3.49% open_in_new
Jul 28, 2022 ☀ PRE $136.12 $145.00 $143.50 35,165 +1.14% open_in_new
Apr 28, 2022 ☀ PRE $150.90 $150.90 $143.36 213,243 -7.47% open_in_new
Feb 10, 2022 ☀ PRE $148.50 $156.57 $151.04 49,672 -0.2% open_in_new
Oct 28, 2021 ☀ PRE $170.00 $171.78 $162.03 237,885 -15.23% open_in_new
Aug 03, 2021 ☀ PRE $178.71 $178.90 $178.90 53,141 +0.51% open_in_new
event

Earnings Count

16

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.29%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
3 20260603 open_in_new SEC.gov
4 20260603 open_in_new SEC.gov
4 20260603 open_in_new SEC.gov
144 20260601 open_in_new SEC.gov
8-K 20260527 open_in_new SEC.gov
4 20260522 open_in_new SEC.gov
4 20260522 open_in_new SEC.gov
4 20260522 open_in_new SEC.gov
4 20260522 open_in_new SEC.gov
4 20260522 open_in_new SEC.gov

Frequently asked about ALNY earnings

When does Alnylam Pharmaceuticals, Inc. Common Stock report earnings next? expand_more

Alnylam Pharmaceuticals, Inc. Common Stock (ALNY)'s next earnings date is estimated for 2026-07-17. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ALNY stock move after earnings? expand_more

Over 16 reports, ALNY has moved an average of ±5.29% the session after earnings, closing higher 50.0% of the time.

What was ALNY's biggest post-earnings move? expand_more

ALNY's largest post-earnings gain on record was +15.47% on Jul 31, 2025, and its largest decline was -15.23% on Oct 28, 2021.

Where can I find Alnylam Pharmaceuticals, Inc. Common Stock's SEC filings? expand_more

All of Alnylam Pharmaceuticals, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers